These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 19665142

  • 1. Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA.
    Ritsner MS, Strous RD.
    J Psychiatr Res; 2010 Jan; 44(2):75-80. PubMed ID: 19665142
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.
    Ritsner M, Gibel A, Maayan R, Ratner Y, Ram E, Modai I, Weizman A.
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):257-64. PubMed ID: 17107774
    [Abstract] [Full Text] [Related]

  • 4. Alterations in DHEA metabolism in schizophrenia: two-month case-control study.
    Ritsner M, Gibel A, Ram E, Maayan R, Weizman A.
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):137-46. PubMed ID: 16139994
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ, O'Keane V, Miell JP.
    Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921
    [Abstract] [Full Text] [Related]

  • 7. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.
    Ritsner M, Maayan R, Gibel A, Strous RD, Modai I, Weizman A.
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):267-73. PubMed ID: 15163435
    [Abstract] [Full Text] [Related]

  • 8. Blood DHEAS concentrations correlate with cognitive function in chronic schizophrenia patients: a pilot study.
    Silver H, Knoll G, Isakov V, Goodman C, Finkelstein Y.
    J Psychiatr Res; 2005 Nov; 39(6):569-75. PubMed ID: 16157159
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH, Härle P, Yamana S, Matsuda T, Takasugi K, Kishimoto T, Nishimoto N.
    Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial.
    MacKenzie T, Comi R, Sluss P, Keisari R, Manwar S, Kim J, Larson R, Baron JA.
    Metabolism; 2007 Dec; 56(12):1694-8. PubMed ID: 17998023
    [Abstract] [Full Text] [Related]

  • 14. Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia.
    Gallagher P, Watson S, Smith MS, Ferrier IN, Young AH.
    Biol Psychiatry; 2005 Jan 15; 57(2):155-61. PubMed ID: 15652874
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
    Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R.
    Arch Gen Psychiatry; 2006 Jun 15; 63(6):630-8. PubMed ID: 16754836
    [Abstract] [Full Text] [Related]

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec 15; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 18. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.
    Fagerlund B, Søholm B, Fink-Jensen A, Lublin H, Glenthøj BY.
    Clin Neuropharmacol; 2007 Dec 15; 30(1):3-12. PubMed ID: 17272964
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB, Anil Yağcioğlu AE, Alptekin K, Turgut TI, Tümüklü M, Yazici MK, Jayathilake K, Tunca Z, Göğüş A, Meltzer HY.
    J Clin Psychiatry; 2006 Dec 15; 67(12):1912-9. PubMed ID: 17194269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.